Publications dans lesquelles il/elle collabore avec JOSE MARIA ESTRELA ARIGÜEL (18)

2024

  1. Nicotinamide riboside, pterostilbene and ibudilast protect motor neurons and extend survival in ALS mice

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, Vol. 21, Núm. 1, pp. e00301

2023

  1. Combination of natural polyphenols with a precursor of NAD+ and a TLR2/6 ligand lipopeptide protects mice against lethal γ radiation

    Journal of Advanced Research, Vol. 45, pp. 73-86

  2. Externally Applied Electromagnetic Fields and Hyperthermia Irreversibly Damage Cancer Cells

    Cancers, Vol. 15, Núm. 13

  3. Survival Mechanisms of Metastatic Melanoma Cells: The Link between Glucocorticoids and the Nrf2-Dependent Antioxidant Defense System

    Cells, Vol. 12, Núm. 3

2022

  1. N-Acetylcysteine Promotes Metastatic Spread of Melanoma in Mice

    Cancers, Vol. 14, Núm. 15

  2. Nuclear and Radiological Emergencies: Biological Effects, Countermeasures and Biodosimetry

    Antioxidants, Vol. 11, Núm. 6

2021

  1. An intercellular flow of glutathione regulated by interleukin 6 links astrocytes and the liver in the pathophysiology of amyotrophic lateral sclerosis

    Antioxidants, Vol. 10, Núm. 12

  2. Melanoma in the liver: Oxidative stress and the mechanisms of metastatic cell survival

    Seminars in Cancer Biology, Vol. 71, pp. 109-121

  3. NAD+ precursors and antioxidants for the treatment of amyotrophic lateral sclerosis

    Biomedicines, Vol. 9, Núm. 8

  4. Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1G93A Mice

    Molecular Neurobiology, Vol. 58, Núm. 4, pp. 1345-1371

  5. Pterostilbene in cancer therapy

    Antioxidants, Vol. 10, Núm. 3, pp. 1-17

  6. The link between oxidative stress, redox status, bioenergetics and mitochondria in the pathophysiology of als

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

2020

  1. Oxidative stress, neuroinflammation and mitochondria in the pathophysiology of amyotrophic lateral sclerosis

    Antioxidants, Vol. 9, Núm. 9, pp. 1-16

  2. Radioprotection and radiomitigation: From the bench to clinical practice

    Biomedicines, Vol. 8, Núm. 11, pp. 1-57

2019

  1. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 20, Núm. 1-2, pp. 115-122

  2. Oxidative stress and antioxidants in the pathophysiology of malignant melanoma

    Biological Chemistry, Vol. 400, Núm. 5, pp. 589-612

2017

  1. Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy

    Journal of Medicinal Chemistry, Vol. 60, Núm. 23, pp. 9413-9436

2016

  1. Pterostilbene Decreases the Antioxidant Defenses of Aggressive Cancer Cells in Vivo: A Physiological Glucocorticoids-and Nrf2-Dependent Mechanism

    Antioxidants and Redox Signaling, Vol. 24, Núm. 17, pp. 974-990